Clifford G. Adlerz serves as Director of the Company. Mr. Adlerz previously served as a Consultant to Surgery Partners from February 2018 until May 2019 and Interim Chief Executive Officer of Surgery Partners from September 2017 until January 2018. Before his time at Surgery Partners, Mr. Adlerz held several management roles at Symbion, Inc., a large multi-specialty provider of ambulatory surgery centers and hospitals, including as President from May 2002 until Symbion was acquired by Surgery Partners in November 2014. Prior to joining Symbion, Mr. Adlerz served as Division Vice President of HCA, a healthcare facilities operator, as well as Regional Vice President of Midsouth HealthTrust. Mr. Adlerz currently serves on the Board of Directors of Ovation Fertility. Mr. Adlerz previously served as a director for the National Ambulatory Surgery Center Association and was part of the leadership group for ASC Quality Collaboration. Mr. Adlerz holds a B.A. in Business and an M.B.A. from the University of Florida. Our Board believes that Mr. Adlerz is qualified to serve as a director based on, among other things, his experience with the Company and its predecessor as well as in the healthcare industry generally and his general business and financial acumen.
As the Director of Surgery Partners Inc, the total compensation of Clifford Adlerz at Surgery Partners Inc is $215,000. There are 12 executives at Surgery Partners Inc getting paid more, with J. Eric Evans having the highest compensation of $4,644,930.
Clifford Adlerz is 66, he's been the Director of Surgery Partners Inc since 2017. There are no older and 21 younger executives at Surgery Partners Inc.
Clifford's mailing address filed with the SEC is C/O SURGERY PARTNERS, INC., 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD, TN, 37027.
Over the last 9 years, insiders at Surgery Partners Inc have traded over $1,643,866,633 worth of Surgery Partners Inc stock and bought 83,000 units worth $1,133,800 . The most active insiders traders include T. Devin O'reilly, Surgery Centers, Llchig Gp ... oraz Capital Investors Llcbcpe S.... On average, Surgery Partners Inc executives and independent directors trade stock every 26 days with the average trade being worth of $26,258,040. The most recent stock trade was executed by Harrison R. Bane on 1 September 2024, trading 6,325 units of SGRY stock currently worth $196,771.
surgery partners is a leading operator of surgical facilities and ancillary services with more than 180 locations nationwide. we provide exceptional integrated healthcare experiences between our providers and patients. our diverse company operates multiple types of healthcare services dedicated to improving the quality of care in a convenient and cost-effective manner. the support of our ancillary services is one of many unique attributes that differentiate us from our competitors. these services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. our integrated approach to advancing markets allows for flexibility to provide care on an individualized, local market basis. whether entering into a new market with surgical facilities, ancillary services or joint ventures with health systems, or furthering an existing market’s growth potential by focusing on base busines
Surgery Partners Inc executives and other stock owners filed with the SEC include: